GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
Hosted on MSN11mon
GSK expands Asia-Pacific reach for Trelegy Ellipta with Singapore approval
Singapore’s Health Sciences Authority (HSA) has expanded the label of GlaxoSmithKline (GSK)’s Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to ...
pharmaphorum1d
FDA set to decide on GSK's gepotidacin antibiotic in March
according to GSK. At the same time, antimicrobial resistance (AMR) to common drugs used to treat these infections is on the rise, leading to treatment failure, with a Singapore study published ...
New York Post5d
FDA greenlights GSK’s drug for UTIs in women and girls
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
Yahoo Finance26d
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and value of GSK Plc's (NYSE:GSK) chronic obstructive pulmonary disease (COPD ...
The Business Times12d
Pfizer sells entire Haleon stake for US$3.24 billion
Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...